CHMP maintains negative opinion on MaaT Pharma’s MaaT013
MaaT Pharma said the CHMP upheld its negative opinion on the CMA for MaaT013 (Xervyteg®) after re-examination.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.